Non-surgical extirpation of a non-infectious expanding tricuspid valve mass by percutaneous aspiration thrombectomy
Related Experiment Video
Updated: Aug 25, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Blerina Asllanaj1, Alexander Urzua1, Anthony Dota2
1Department of Internal Medicine, HCA Healthcare, MountainView Hospital, Las Vegas, Nevada, USA.
Abstract:
Marantic endocarditis refers to a noninfectious lesion, usually in the aortic and mitral valves, that is most commonly seen in advanced malignancy and systemic lupus erythematosus. Inflammatory conditions, including antiphospholipid syndrome (APS), are a rare etiology making up less than 20% of reported cases. The condition is thought to be due to a hypercoagulable state and found postmortem with rates in autopsy series ranging from 0.9% to 1.6%. In comparison to infective endocarditis, marantic endocarditis has a greater tendency for valve vegetations to embolize. Common treatment modalities include anticoagulation or valve replacement. Although percutaneous aspiration thrombectomy of right-sided heart chamber thrombi exists, there are limited reports demonstrating its use with regards to treatment of right-sided endocarditis. We present the case of an older male with a history of Factor V Leiden and APS who was admitted due to a rapidly expanding mass on the tricuspid valve (TV). Despite serial blood cultures being negative, the patient received adequate antibiotic therapy for more than 4 weeks. Transthoracic echocardiogram showed an enlarged TV vegetation with an increased diameter from 10 to 30 mm over 6 weeks. Due to the patient's high operative risk and concern for embolization complications, a multidisciplinary decision was made to perform percutaneous aspiration thrombectomy of the TV vegetation. Subsequent biopsy of the lesion confirmed it was noninfectious and nonmalignant. Thus, the patient was started on systemic anticoagulation for prevention of thromboembolic events.
Insights
Marantic endocarditis, a noninfectious valve condition, can be rare in antiphospholipid syndrome (APS). This case highlights percutaneous aspiration thrombectomy as a viable treatment for tricuspid valve vegetation in high-risk patients.
Area of Science:
- Cardiology
- Hematology
Background:
- Marantic endocarditis involves noninfectious valve lesions, often linked to malignancy or systemic lupus erythematosus.
- Antiphospholipid syndrome (APS) is a rare cause of marantic endocarditis, associated with hypercoagulable states.
Observation:
- A patient with Factor V Leiden and APS presented with a rapidly growing tricuspid valve mass.
- Transthoracic echocardiography revealed significant vegetation growth over six weeks.
- Blood cultures were negative, and the patient completed antibiotic therapy without resolution.
Findings:
- Percutaneous aspiration thrombectomy was performed due to high surgical risk and embolization concerns.
- Biopsy confirmed the vegetation was noninfectious and nonmalignant.
- The patient was initiated on systemic anticoagulation post-procedure.
Implications:
- Percutaneous aspiration thrombectomy is a potential treatment for right-sided heart chamber vegetations in selected high-risk patients.
- This case expands treatment options for marantic endocarditis, particularly in the context of APS.
- Effective management involves addressing the underlying hypercoagulable state and preventing thromboembolic events.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

